Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-17

Clinical Trial Update: Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating hepatic arterial infusion with floxuridine and dexamethasone in combination chemotherapy for colorectal cancer that has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Floxuridine (floxuridine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING